Karen J. Wilson
Director, Vaxart.
Companies
- Connect Biopharma Holdings LtdBoard member Mar 16, 2026 to now1
- Serina Therapeutics, Inc.Board member Jan 15, 2025 to now2
- LAVA Therapeutics NVBoard member Jan 2, 2025 to now3
- Elicio Therapeutics, Inc.Board member Feb 4, 2021 to now4
- VaxartBoard member Aug 27, 2020 to Jun 17, 20215
- Jazz PharmaceuticalsVP of Finance & PAO Mar 9, 2011 to Mar 7, 20196
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Serina Therapeutics, Inc. SER30,100 shares7$50.9K at $1.69Jun 22, 2026
- Connect Biopharma Holdings Ltd CNTB10,000 shares8$8.9K at $0.89Mar 16, 2026
- LAVA Therapeutics NV0 shares9Nov 13, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 12, 2026Bought 5,000 shares at $1.77 of Serina Therapeutics, Inc.10
- Jun 11, 2026Bought 5,100 shares at $1.75 of Serina Therapeutics, Inc.10
- May 22, 2026Bought 10,000 shares at $1.93 of Serina Therapeutics, Inc.11
- May 21, 2026Bought 10,000 shares at $1.77 of Serina Therapeutics, Inc.11
- Nov 13, 2025Returned to company 10,000 shares of LAVA Therapeutics NV9
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARLAVA Therapeutics NV, Board member
- 4
- 5SEC EDGARVaxart, Board member
- 6
- 7
- 8
- 9
- 10SEC EDGARForm 4 filed Jun 15, 2026
- 11SEC EDGARForm 4 filed May 26, 2026